54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 09
00:55 UTC
|
AER
Aercap
|
◎ Target | Arren Cyganovich ★★★☆☆ #1986 | Buy | $161.00→ $175.00+8.7% |
|
Jul 09
00:55 UTC
|
ADP
Automatic Data Processing
|
◎ Target | David Grossman ★★★☆☆ #1616 | Hold | $240.00→ $260.00+8.3% |
|
Jul 09
00:55 UTC
|
ACGL
Arch Capital Group
|
◎ Target | Meyer Shields ★★★☆☆ #1618 | Market Perform | $102.00→ $99.00-2.9% |
|
Jul 09
00:55 UTC
|
AC
Air Canada
|
◎ Target | firm only | Outperform | C$26.00→ C$30.00+15.4% |
|
Jul 09
00:55 UTC
|
UHS
Universal Health Services
|
↓ Downgrade | Andrew Mok not yet tracked | Overweight→ Negative | |
|
Jul 09
00:55 UTC
|
SBRA
Sabra Healthcare REIT
|
↓ Downgrade | Michael Lewis ★★★☆☆ #1214 | Buy→ Hold | |
|
Jul 09
00:55 UTC
|
RIO
Rio Tinto
|
↓ Downgrade | firm only | Equal Weight→ Underweight | |
|
Jul 09
00:55 UTC
|
PGPHF
Partners Group
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Jul 09
00:55 UTC
|
HCA
HCA Healthcare
|
↓ Downgrade | Andrew Mok not yet tracked | Overweight→ Negative | |
|
Jul 09
00:55 UTC
|
GLOB
Globant
|
↓ Downgrade | Maria Clara Infantozzi not yet tracked | Outperform→ Market Perform | $39.00 |
|
Jul 09
00:55 UTC
|
DLTR
Dollar Tree
|
↓ Downgrade | Kate McShane ★★☆☆☆ #2411 | Neutral→ Sell | |
|
Jul 09
00:55 UTC
|
CYH
Community Health Systems
|
↓ Downgrade | Andrew Mok not yet tracked | Equal Weight→ Underweight | $3.00 |
|
Jul 09
00:55 UTC
|
CRM
Salesforce
|
↓ Downgrade | Jackson Ader ★★★☆☆ #1334 | Overweight→ Sector Weight | |
|
Jul 09
00:55 UTC
|
BBWI
Bath & Body Works
|
↓ Downgrade | Kate McShane ★★☆☆☆ #2411 | Neutral→ Sell | $23.00→ $19.00-17.4% |
|
Jul 09
00:55 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
↓ Downgrade | firm only | Overweight | |
|
Jul 09
00:55 UTC
|
APEMY
Aperam
|
↓ Downgrade | firm only | Neutral→ Underperform | |
|
Jul 09
00:55 UTC
|
ANIOY
Acerinox
|
↓ Downgrade | firm only | Neutral→ Underperform | |
|
Jul 09
00:55 UTC
|
UGP
Ultrapar Participacoes
|
↑ Upgrade | Leonardo Marcondes ★★☆☆☆ #2762 | Neutral→ Buy | $6.80→ $7.40+8.8% |
|
Jul 09
00:55 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | firm only | Outperform | $10.00 |
|
Jul 09
00:55 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | Ryan Deschner ★★★★☆ #658 | Market Perform→ Outperform | $10.00 |
|
Jul 09
00:55 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | Yasmeen Rahimi ★★★☆☆ #1696 | Neutral→ Overweight | $13.00 |
|
Jul 09
00:55 UTC
|
TTD
Trade Desk
|
↑ Upgrade | Mohammed Khallouf ★★★☆☆ #2209 | Reduce→ Hold | $20.00 |
|
Jul 09
00:55 UTC
|
RH
RH
|
↑ Upgrade | Kate McShane ★★☆☆☆ #2411 | Sell→ Neutral | $86.00→ $155.00+80.2% |
|
Jul 09
00:55 UTC
|
PRG
PROG
|
↑ Upgrade | John Hecht ★★★☆☆ #1892 | Hold→ Buy | $33.00→ $60.00+81.8% |
|
Jul 09
00:55 UTC
|
OXY
Occidental Petroleum
|
↑ Upgrade | firm only | In-Line→ Outperform | $65.00 |
|
Jul 09
00:55 UTC
|
ODFL
Old Dominion Freight Line
|
↑ Upgrade | Christian Wetherbee ★☆☆☆☆ #2969 | Underweight→ Overweight | $235.00→ $250.00+6.4% |
|
Jul 09
00:55 UTC
|
IVPAF
Ivanhoe Mines
|
↑ Upgrade | firm only | Negative→ Overweight | |
|
Jul 09
00:55 UTC
|
IVN
Ivanhoe Mines
|
↑ Upgrade | firm only | Equal Weight→ Overweight | C$12.00→ C$13.20+10.0% |
|
Jul 09
00:55 UTC
|
DLTR
Dollar Tree
|
↑ Upgrade | Corey Tarlowe ★★★★☆ #455 | Underperform→ Buy | |
|
Jul 09
00:55 UTC
|
DLTR
Dollar Tree
|
↑ Upgrade | Michael Montani ★★★☆☆ #1885 | Positive→ Outperform | |
|
Jul 09
00:55 UTC
|
DLTR
Dollar Tree
|
↑ Upgrade | Bobby Griffin ★★★★☆ #401 | Market Perform→ Outperform | $140.00 |
|
Jul 09
00:55 UTC
|
CNK
Cinemark
|
↑ Upgrade | firm only | Sell→ Neutral | |
|
Jul 09
00:55 UTC
|
CMPS
Compass Pathways
|
↑ Upgrade | firm only | In-Line→ Outperform | $21.00 |
|
Jul 09
00:55 UTC
|
CMC
Commercial Metals
|
↑ Upgrade | firm only | Neutral→ Outperform | $75.00 |
|
Jul 09
00:55 UTC
|
AMT
American Tower
|
↑ Upgrade | firm only | Outperform | $188.00 |
|
Jul 09
00:55 UTC
|
ALGT
Allegiant Travel
|
↑ Upgrade | Atul Maheswari ★★☆☆☆ #2740 | Neutral→ Buy | |
|
Jul 08
23:55 UTC
|
CNK
Cinemark
|
↑ Upgrade | firm only | Sell→ Neutral | |
|
Jul 08
23:55 UTC
|
AMT
American Tower
|
↑ Upgrade | firm only | Outperform | $188.00 |
|
Jul 08
22:55 UTC
|
AMT
American Tower
|
↑ Upgrade | firm only | Outperform | |
|
Jul 08
20:55 UTC
|
PGPHF
Partners Group
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Jul 08
20:55 UTC
|
TVRD
Tvardi Therapeutics
|
↑ Upgrade | Yasmeen Rahimi ★★★☆☆ #1696 | Neutral→ Overweight | $13.00 |
|
Jul 08
19:55 UTC
|
PJT
PJT Partners
|
◎ Target | Michael Brown ★★★☆☆ #1534 | Neutral | $160.00→ $162.00+1.2% |
|
Jul 08
19:55 UTC
|
PARR
Par Pacific
|
◎ Target | Manav Gupta ★★★★☆ #867 | Neutral | $60.00→ $65.00+8.3% |
|
Jul 08
19:55 UTC
|
PACS
PACS Group
|
◎ Target | A.J. Rice ★★★★☆ #708 | Buy | $50.00→ $57.00+14.0% |
|
Jul 08
19:55 UTC
|
MRSH
Marsh & McLennan Companies
|
◎ Target | Brian Meredith ★★★☆☆ #1239 | Buy | $203.00→ $212.00+4.4% |
|
Jul 08
19:55 UTC
|
MET
MetLife
|
◎ Target | Michael Ward ★★★☆☆ #2047 | Buy | $102.00→ $105.00+2.9% |
|
Jul 08
19:55 UTC
|
LNC
Lincoln National
|
◎ Target | Michael Ward ★★★☆☆ #2047 | Neutral | $39.00→ $44.00+12.8% |
|
Jul 08
19:55 UTC
|
KALU
Kaiser Aluminum
|
◎ Target | Alex Stansbury not yet tracked | Neutral | $176.00→ $179.00+1.7% |
|
Jul 08
19:55 UTC
|
INVH
Invitation Home
|
◎ Target | Michael Goldsmith ★★★★☆ #716 | Buy | $32.00→ $35.00+9.4% |
|
Jul 08
19:55 UTC
|
HR
Healthcare Realty Trust
|
◎ Target | Michael Goldsmith ★★★★☆ #716 | Neutral | $20.00→ $21.00+5.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.